Grace Halsey

Pfizer announced that a single dose of the vaccine, RSVpreF, demonstrated 85.7% efficacy against severe disease, defined by ≥3 symptoms.

Widespread antibiotic prescribing in the first year of the pandemic set back US progress on the fight against antimicrobial resistance, says Anne Meneghetti, MD.

The dextromethorphan HBr-bupropion HCI combination uses the first new oral MOA in 6 decades and is labeled to improve depressive symptoms starting at 1 week.

Youth newly diagnosed with T2D also were metabolically sicker, with higher HbA1c, serum glucose levels, and BMI at presentation.

Influenza season in the southern hemisphere is "substantial," says Dr William Schaffner. To prepare: "Vaccinate, vaccinate, vaccinate!"

The recommendations guide initiation of statin therapy in persons aged ≥40 years without a history of CVD and no current signs/symptoms of CVD.

The patients on the vaccine fence are the ones that take the extra time and, over time, an added measure of patience for the clinician.

Moderna filed with the FDA for emergency use authorization of a 50-µg dose of a BA.4./BA.5 Omicron-targeting bivalent booster vaccine for those aged ≥18 years.

Phase II clinical trial shows a fixed dose combination of semaglutide/cagrilintide reduces HbA1c and weight much better than either drug alone.

Among more than 26 000 women, a vegetarian diet was associated with a 33% greater risk of hip fracture vs diets that included fish or meat.

Vaccine fatigue in the US, says Vanderbilt University's William Schaffner, MD, is plentiful for vaccines that are are good—but not perfect.

Let's call the next round of COVID-19 shots "updated vaccines," and help the public understand the true role of this vaccination, says NFID's Schaffner.

Respiratory virus season is top of mind for Schaffner, medical director of the National Foundation for Infectious Diseases, and he says it's going to be a challenge.

Pair the risk of side effects associated with a COVID-19 shot with the risk of death in a car accident and see what happens. It worked in this study.

Racial disparities in gout prevalence could be explained by diet, social determinants of health, kidney disease, and other factors that suggest interventions.

Vaccine hesitancy and actual refusal can wear on clinicians over time; family physician Gretchen LaSalle, MD, offers potential antidotes to the frustration.

Listening to patient concerns about vaccines and guiding them to factual sources for answers pays off, says family physician Gretchen LaSalle, MD.

Blood pressure reduction of approximately 11 mm Hg was seen at 6 months regardless of device used, suggesting patients can keep SMBP simple.

Adult vaccine awareness in the US is historically low and complicated this year by booster fatigue and lots of catch-up, says family physician Gretchen LaSalle, MD.

Vaccine hesitancy didn't begin with COVID but family physician Gretchen LaSalle, MD, says the pandemic has changed the tone of the reluctance. She explains in this interview.

Meta-analysis authors say the significant preventive effects of replacing use of salt with salt substitutes have important worldwide public health implications.

Analysis of 224 000 type 2 diabetes patients over 2 decades suggests the need for "revised care pathways" that better reflect the myriad causes of persistent morbidity.

Screening for atrial fibrillation with 6 wrist-worn wearable devices proved more cost effective than no screening and had greater relative benefit than using traditional modalities.

A smaller dose given by intradermal injection will expand the total US supply by a factor of 5, FDA says.

Use of wearable activity trackers increased daily time spent walking by 40 minutes and was linked to a 2-lb weight loss across age groups and populations.

Influenza, SARS-CoV-2, and RSV: 4 drug makers have all 3 viruses targeted for vaccines, alone and in combination. Click through the flash-card update.

Earlier age at hypertension onset could lead to greater cumulative exposure to elevated BP, exposure known to increase risk of CVD and that could lead to disparities in outcomes.

A diagnosis of NAFLD was associated with a 50% greater risk of new-onset heart failure in a meta-analysis comprised of more than 11 million individuals.

Antiplatelet medication was associated with a 63% increase in heat-related MI risk and ß-blockers with a 65% increase. People taking both drugs had a 75% higher risk.

A real-world study found that a delay in diagnosis of 1 year or more was particularly detrimental to patients with mild disease at time of diagnosis.